$12.36
-0.20-1.59%
In chiusura: Nov 13, 4:00 PM EST
$12.36
-0.20-1.59%
Pre-mercato: 7:00 AM EST

The average analyst price target for Obsidian Therapeutics is $39, 215.5% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $32 to $43. The latest change came on Sep 22, 2026, when Leerink Partners initiated coverage of Obsidian Therapeutics with an Outperform rating and a $32 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months